FGH BioTech is Drug Discovery in United States that focus on fatty liver disease business. Founded in 2011. They cover business area such as developer, small molecule drug, metabolic disorder, cancer, fat production, sterol regulatory element-bind protein, SREBP, physician, obesity, non-alcoholic fatty liver disease, type ii diabetes, lipid disorder.
2011
( 13 years old in 2024 )
Fatty Liver Disease
-
414 Thamer Circle
Houston, TX 77024
United States
Private
developersmall molecule drugmetabolic disordercancerfat productionsterol regulatory element-bind proteinSREBPphysicianobesitynon-alcoholic fatty liver diseasetype ii diabeteslipid disorder
* We use standard office opening hours in near FGH BioTech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
FGH BioTech is Drug Discovery business from United States that founded in 2011 (13 years old in 2024), FGH BioTech business is focusing on Fatty Liver Disease.
FGH BioTech headquarter office and corporate office address is located in 414 Thamer Circle Houston, TX 77024 United States.
FGH BioTech was founded in United States.
In 2024, FGH BioTech is currently focus on fatty liver disease sector.
Above is snippet of Google Trends for "fatty liver disease" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with FGH BioTech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
